Disarm Therapeutics
Peter is a Professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center and the Division of Neuroimmunology and Neuroinfectious Diseases.
Peter earned a BS from Yale College, MD from Brown University, and completed a research fellowship at the National Institutes of Health (NIH). He has been the principal investigator on several clinical trials and also oversees translational laboratory research projects. He is the recipient of a Jacob Javits Neuroscience Investigator award from the NIH. Peter also recently received the Barancik Award for Innovation in MS research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company that creates disease-modifying therapeutics for patients with axonal degeneration. Its drugs prevent the loss of axons and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies that enable patients to avail treatment for acutediseases of the central, ocular, and peripheral nervous systems.